Status:
COMPLETED
Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects
Lead Sponsor:
JW Pharmaceutical
Conditions:
Hyperlipidemia
Hypertension
Eligibility:
MALE
20-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.
Eligibility Criteria
Inclusion
- Healthy male volunteers
- Age 20-55 years at the time of Screening
- BMI 19-26 kg/m2 at the time of Screening
Exclusion
- Received other investigational drug within 90 days prior to the first dose of study drug
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01406431
Start Date
August 1 2011
End Date
October 1 2012
Last Update
January 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea